Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825213 · ClinicalTrials.gov registry record
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 10
- Enrollment target
NCT01825213: Completed study, sponsored by Massachusetts General Hospital.
NCT01825213 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01825213 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility to stratify liver fibrosis in patients with chronic liver disease through non-invasive, spectral CT.
Interventions
- DEVICE Multispectral CT of the liver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01825213
The ClinicalTrials.gov registry entry for NCT01825213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multispectral CT of the liver is the first listed.
NCT01825213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01825213 about?
NCT01825213 is a clinical study titled "Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT". The purpose of this study is to evaluate the feasibility to stratify liver fibrosis in patients with chronic liver disease through non-invasive, spectral CT.
What is the current status of trial NCT01825213?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2013-11. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01825213?
The interventions under investigation include: Multispectral CT of the liver (DEVICE).
Who is sponsoring clinical trial NCT01825213?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.